This website is intended for US audiences only. For a full list of participating sites, please visit www.clinicaltrials.gov.

The REACH Phase 3 Clinical Trial is fully enrolled.

We encourage those interested in clinical trial participation to check clinicaltrials.gov and fshdsociety.org for information on other potential trials.